CRISPR screens in Drosophila cells identify Vsg as a Tc toxin receptor - Nature

Deutschland Nachrichten Nachrichten

CRISPR screens in Drosophila cells identify Vsg as a Tc toxin receptor - Nature
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Nature
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

Nature research paper: CRISPR screens in Drosophila cells identify Vsg as a Tc toxin receptor

, Prevalence of all sgRNAs targeting Vsg, Mop, FIG4, or VAC14 across three rounds of pTc or mTc screens were quantified and plotted according to their corresponding gRNA abundances., Schematic of the experimental steps. Briefly, S2 cells were bathed in dsRNAs targeting the top hits from pTc CRISPR screen # 1 round 1 and allowed to recover for 3 days. Next, cells were treated with 100 pM pTc for 2 days, re-seeded and grown for an additional 7 days.

Gate representing DNA content of 80–90% of untreated cells was set. There was no pre-gating on cell sizes as pTc treatment causes changes in cell sizes and shapes., The indicated top hits from pTc CRISPR screens were knocked down in S2 cells using dsRNA and then exposed to pTc as described in . Percentage of cells with normal Hoechst levels were plotted., Comparison of untreated cells versus those treated with 100 pM pTc revealed increase in cell size .

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Nature /  🏆 64. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Visualizing translation dynamics at atomic detail inside a bacterial cell - NatureVisualizing translation dynamics at atomic detail inside a bacterial cell - NatureCryo-electron tomography is used to reveal the structural dynamics and functional diversity of translating ribosomes in Mycoplasma pneumoniae, providing insight into the translation elongation cycle inside cells and how it is reshaped by antibiotics.
Weiterlesen »

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial - Nature MedicineCAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial - Nature MedicineBicistronic CART cells targeting CD19 & CD22 show clinical activity in pediatric & young adult patients w/ B cell acute lymphoblastic leukemia, w/ relapses associated w/ limited CAR T cell persistence. ChildhoodCancerAwarenessMonth NMEDclinical
Weiterlesen »



Render Time: 2025-03-10 05:34:15